178 related articles for article (PubMed ID: 27729281)
1. Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility.
Dam DHM; Wang XQ; Sheu S; Vijay M; Shipp D; Miller L; Paller AS
J Invest Dermatol; 2017 Feb; 137(2):440-448. PubMed ID: 27729281
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors.
Wang XQ; Lee S; Wilson H; Seeger M; Iordanov H; Gatla N; Whittington A; Bach D; Lu JY; Paller AS
J Invest Dermatol; 2014 May; 134(5):1446-1455. PubMed ID: 24326453
[TBL] [Abstract][Full Text] [Related]
3. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown.
Randeria PS; Seeger MA; Wang XQ; Wilson H; Shipp D; Mirkin CA; Paller AS
Proc Natl Acad Sci U S A; 2015 May; 112(18):5573-8. PubMed ID: 25902507
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides in Diabetic Wound Healing.
Dam DHM; Paller AS
Prog Mol Biol Transl Sci; 2018; 156():229-239. PubMed ID: 29747815
[TBL] [Abstract][Full Text] [Related]
5. Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.
Shields SK; Nicola C; Chakraborty C
Endocrinology; 2007 Oct; 148(10):4906-17. PubMed ID: 17640993
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200b/c-3p regulate epithelial plasticity and inhibit cutaneous wound healing by modulating TGF-β-mediated RAC1 signaling.
Tang H; Wang X; Zhang M; Yan Y; Huang S; Ji J; Xu J; Zhang Y; Cai Y; Yang B; Lan W; Huang M; Zhang L
Cell Death Dis; 2020 Oct; 11(10):931. PubMed ID: 33122632
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM3 participates in the pathological conditions of insulin resistance.
Tagami S; Inokuchi Ji J; Kabayama K; Yoshimura H; Kitamura F; Uemura S; Ogawa C; Ishii A; Saito M; Ohtsuka Y; Sakaue S; Igarashi Y
J Biol Chem; 2002 Feb; 277(5):3085-92. PubMed ID: 11707432
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside GM3 synthase depletion reverses neuropathic pain and small fiber neuropathy in diet-induced diabetic mice.
Menichella DM; Jayaraj ND; Wilson HM; Ren D; Flood K; Wang XQ; Shum A; Miller RJ; Paller AS
Mol Pain; 2016; 12():. PubMed ID: 27590073
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor.
Wang XQ; Sun P; Paller AS
J Biol Chem; 2002 Dec; 277(49):47028-34. PubMed ID: 12354760
[TBL] [Abstract][Full Text] [Related]
10. Double duty for Rac1 in epidermal wound healing.
DiPersio CM
Sci STKE; 2007 Jun; 2007(391):pe33. PubMed ID: 17579242
[TBL] [Abstract][Full Text] [Related]
11. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3.
Nagafuku M; Sato T; Sato S; Shimizu K; Taira T; Inokuchi J
Glycobiology; 2015 Mar; 25(3):303-18. PubMed ID: 25303960
[TBL] [Abstract][Full Text] [Related]
12. Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy mice.
Inamori KI; Ito H; Tamura Y; Nitta T; Yang X; Nihei W; Shishido F; Imazu S; Tsukita S; Yamada T; Katagiri H; Inokuchi JI
J Lipid Res; 2018 Aug; 59(8):1472-1481. PubMed ID: 29880531
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites.
Wang XQ; Sun P; Paller AS
J Biol Chem; 2003 Dec; 278(49):48770-8. PubMed ID: 14512423
[TBL] [Abstract][Full Text] [Related]
14. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha3beta1-dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5.
Choma DP; Milano V; Pumiglia KM; DiPersio CM
J Invest Dermatol; 2007 Jan; 127(1):31-40. PubMed ID: 16917494
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway.
Huang X; Li Y; Zhang J; Xu Y; Tian Y; Ma K
J Cell Biochem; 2013 Jul; 114(7):1616-24. PubMed ID: 23355442
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GM3 deficiency enhances mast cell sensitivity.
Komuro M; Mizugaki H; Nagane M; Morimoto M; Fukuyama T; Ogihara K; Naya Y; Yokomori E; Kaneshima K; Kawakami Y; Kamiie J; Shibata Y; Suzuki M; Shimizu T; Kawashima N; Okamoto M; Ikeda T; Yamashita T
FEBS J; 2023 Sep; 290(17):4268-4280. PubMed ID: 37098812
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes.
Chernyavsky AI; Arredondo J; Marubio LM; Grando SA
J Cell Sci; 2004 Nov; 117(Pt 23):5665-79. PubMed ID: 15494367
[TBL] [Abstract][Full Text] [Related]
20. Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1- and EGF-dependent signalling pathways.
Haase I; Evans R; Pofahl R; Watt FM
J Cell Sci; 2003 Aug; 116(Pt 15):3227-38. PubMed ID: 12829742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
